Hepatitis B Research Network Pediatric Cohort Study (HBRN)
NCT01263600 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 462
Last updated 2022-05-31
Summary
The purpose of this study is to describe participants 6 months to \<18 years of age with hepatitis B virus (HBV) infection in a prospective cohort in the United States (US) and Canada and identify predictors of disease activation and progression.
Conditions
Sponsors & Collaborators
-
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
collaborator NIH -
University of Pittsburgh
lead OTHER
Principal Investigators
-
Steven Belle, PhD · University of Pittsburgh
Eligibility
- Min Age
- 6 Months
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-12-31
- Primary Completion
- 2021-06-09
- Completion
- 2021-06-09
Countries
- United States
- Canada
Study Locations
More Related Trials
-
To Evaluate Antiviral Efficacy of Telbivudine in Hepatitis B Antigen Positive (HbeAg-positive) Compensated Chronic Hepatitis B (CHB)
NCT00537537 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
NCT00423891 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Evaluate the Antiviral Efficacy, Safety and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Pediatric Participants With Chronic Hepatitis B Infection
NCT01651403 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus Infection
NCT01079806 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Telbivudine in Patients With Chronic Hepatitis B
NCT00606099 ·Status: WITHDRAWN ·Phase: PHASE4
-
Efficacy of Telbivudine in Blacks/African Americans and Hispanics/Latinos With Compensated Chronic Hepatitis B During 52 Weeks
NCT00862706 ·Status: WITHDRAWN ·Phase: PHASE4
-
Randomized Controlled Study of Tenofovir Plus Telbivudine Versus Monotherapy With Either Drug in HBeAg Negative Chronic Hepatitis B Patients
NCT01260610 ·Status: WITHDRAWN ·Phase: NA
-
Efficacy Study of Telbivudine in Chronic Hepatitis B Patients
NCT01958229 ·Status: COMPLETED
-
HepB mAb19 in Individuals With Chronic Hepatitis B Infection
NCT05856890 ·Status: RECRUITING ·Phase: PHASE1
-
Study to Investigate the Safety and Efficacy of BRII-835 and BRII-179 Combination Therapy Treating Chronic Hepatitis B Virus (HBV) Infection
NCT04749368 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess DV-601 in Subjects With Chronic Hepatitis B
NCT01023230 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Telbivudine and Lamivudine to Prevent Vertical Transmission of Hepatitis B
NCT01743079 ·Status: COMPLETED ·Phase: PHASE4
-
Molecular Characteristics of Hepatitis B Virus Integration, Mutation, and Drug Resistance
NCT06779864 ·Status: RECRUITING
-
A Registry for Adolescent and Pediatric Participants Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials
NCT02510300 ·Status: TERMINATED
-
Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B
NCT01369199 ·Status: TERMINATED ·Phase: PHASE3
-
Study of Efficacy and Safety, Tolerability and Pharmacokinetics of Telbivudine in Children and Adolescents With Compensated Chronic Hepatitis B Virus Infection
NCT02058108 ·Status: TERMINATED ·Phase: PHASE3
-
Use of TDF in Patients With Inactive Chronic Hepatitis B Infection
NCT02600117 ·Status: COMPLETED ·Phase: PHASE3
-
Sustained Viral Response in Chronic Hepatitis B Patients Who Achieved HBeAg Seroncongversion After Interferon Therapy
NCT02412592 ·Status: UNKNOWN
-
An Extension to Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B
NCT00467545 ·Status: COMPLETED ·Phase: PHASE4
-
Hepatitis B Virus (HBV) Viral Suppression by Entecavir in Adefovir Partial Responders
NCT00704106 ·Status: COMPLETED
-
A Real-World Observational Study for the Safety and Efficacy of Baraclude in Korean Pediatric Patients With Chronic Hepatitis B
NCT03426618 ·Status: COMPLETED
-
A Real-World Study of Antiviral Therapy in Children With Chronic Hepatitis B
NCT06926647 ·Status: NOT_YET_RECRUITING
-
Study of the Immunogenicity and Efficacy of HBsAg Vaccine in Combination With Standard Antiviral Therapy With HB110E
NCT01813487 ·Status: COMPLETED ·Phase: NA
-
Stopping Antiviral Treatment in Chronic Hepatitis B
NCT04431245 ·Status: ACTIVE_NOT_RECRUITING
-
Persistence, Adherence and Clinical Effectiveness of Entecavir in Chronic Hepatitis B Patients
NCT01356901 ·Status: COMPLETED